• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Director Steiner Gerald A was granted 2,762 shares, increasing direct ownership by 33% to 11,012 units (SEC Form 4)

    7/3/25 3:34:12 PM ET
    $ALB
    Major Chemicals
    Industrials
    Get the next $ALB alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    STEINER GERALD A

    (Last) (First) (Middle)
    ALBEMARLE CORPORATION
    4250 CONGRESS STREET, SUITE 900

    (Street)
    CHARLOTTE NC 28209

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    ALBEMARLE CORP [ ALB ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    07/01/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 07/01/2025 A 2,725(1) A $0 10,975 D
    Common Stock 07/01/2025 A 37(2) A $0 11,012 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. Shares represent an annual installment of non-employee director stock compensation pursuant to the 2023 Stock Compensation and Deferral Election Plan for Non-Employee Directors of Albemarle Corporation (the "2023 Directors Plan"). Shares to vest on July 1, 2026.
    2. Represents dividends accrued on shares underlying an award granted on July 1, 2024, that vested in full on July 1, 2025, which the Issuer elected to settle in shares of common stock under the 2023 Directors Plan.
    Remarks:
    Exhibit 24 - Power of Attorney
    /s/ Rebekah Richards, Attorney-in-Fact 07/03/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $ALB alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALB

    DatePrice TargetRatingAnalyst
    7/30/2025Overweight → Sector Weight
    KeyBanc Capital Markets
    7/29/2025$60.00Neutral → Underperform
    Robert W. Baird
    7/11/2025$57.00Neutral → Sell
    UBS
    2/5/2025Outperform → In-line
    Evercore ISI
    1/28/2025$96.00Hold
    Truist
    1/14/2025$112.00Buy
    Clarksons Platou
    8/5/2024$102.00 → $85.00Outperform → Neutral
    Robert W. Baird
    7/31/2024$160.00 → $83.00Buy → Hold
    Berenberg
    More analyst ratings

    $ALB
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Albemarle Announces Enhanced Organizational Structure

    Aligns the company's functional model for greater agility and efficiency and is designed to accelerate market-led growth and operational excellence CHARLOTTE, N.C., Aug. 11, 2025 /PRNewswire/ -- Albemarle Corporation (NYSE:ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced changes to its organizational structure to further align the company for agility and efficiency. These enhancements are designed to accelerate the company's market-led enterprise strategy and focus on operational excellence. Effective as of to

    8/11/25 4:15:00 PM ET
    $ALB
    Major Chemicals
    Industrials

    Albemarle Announces New General Counsel, Corporate Secretary and Chief Compliance Officer

    CHARLOTTE, N.C., July 30, 2025 /PRNewswire/ -- Albemarle Corporation (NYSE:ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, announced today that Ander Krupa has been promoted to executive vice president, general counsel, corporate secretary and chief compliance officer. "Ander's demonstrated leadership, broad legal expertise, and deep institutional knowledge positions him well to assume strategic oversight of Albemarle's legal, ethics, risk, and compliance functions," said Kent Masters, Albemarle's Chairman and CEO. "We are c

    7/30/25 4:30:00 PM ET
    $ALB
    Major Chemicals
    Industrials

    Albemarle Reports Second Quarter 2025 Results

    CHARLOTTE, N.C., July 30, 2025 /PRNewswire/ -- Albemarle Corporation (NYSE:ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced its results for the second quarter ended June 30, 2025. Second-Quarter 2025 and Recent Highlights(Unless otherwise stated, all percentage changes represent year-over-year comparisons) Net sales of $1.3 billion, including volume growth in Energy Storage (+15%) and Specialties (+6%).Net income of $23 million, or ($0.16) per diluted share attributable to common shareholders; adjusted diluted

    7/30/25 4:15:00 PM ET
    $ALB
    Major Chemicals
    Industrials

    $ALB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    General Counsel & Sec Krupa Ander C. was granted 7,430 shares, increasing direct ownership by 171% to 11,771 units (SEC Form 4)

    4 - ALBEMARLE CORP (0000915913) (Issuer)

    8/8/25 4:16:45 PM ET
    $ALB
    Major Chemicals
    Industrials

    New insider Krupa Ander C. claimed ownership of 4,341 shares (SEC Form 3)

    3 - ALBEMARLE CORP (0000915913) (Issuer)

    8/8/25 4:16:01 PM ET
    $ALB
    Major Chemicals
    Industrials

    Director Oconnell Diarmuid B. was granted 2,762 shares, increasing direct ownership by 50% to 8,233 units (SEC Form 4)

    4 - ALBEMARLE CORP (0000915913) (Issuer)

    7/3/25 3:35:31 PM ET
    $ALB
    Major Chemicals
    Industrials

    $ALB
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Coleman Kristin M. bought $167,314 worth of shares (1,373 units at $121.86) (SEC Form 4)

    4 - ALBEMARLE CORP (0000915913) (Issuer)

    11/7/23 4:39:49 PM ET
    $ALB
    Major Chemicals
    Industrials

    $ALB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Albemarle downgraded by KeyBanc Capital Markets

    KeyBanc Capital Markets downgraded Albemarle from Overweight to Sector Weight

    7/30/25 7:24:56 AM ET
    $ALB
    Major Chemicals
    Industrials

    Albemarle downgraded by Robert W. Baird with a new price target

    Robert W. Baird downgraded Albemarle from Neutral to Underperform and set a new price target of $60.00

    7/29/25 7:36:15 AM ET
    $ALB
    Major Chemicals
    Industrials

    Albemarle downgraded by UBS with a new price target

    UBS downgraded Albemarle from Neutral to Sell and set a new price target of $57.00

    7/11/25 8:09:46 AM ET
    $ALB
    Major Chemicals
    Industrials

    $ALB
    Leadership Updates

    Live Leadership Updates

    View All

    Ketjen Announces the Appointment of Henri Tausch as Chief Commercial Officer

    Ketjen Corporation, a leader in catalyst and specialty chemicals manufacturing, today announces the appointment of Henri Tausch to Chief Commercial Officer (CCO) effective June 24, 2024. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240619765799/en/Henri Tausch, Ketjen Chief Commercial Officer (Photo: Business Wire) In his role as Chief Commercial Officer, Tausch will oversee and advance the company's commercial strategy, and foster key partnerships to accelerate the company's global growth trajectory. "I am honored to join Ketjen and contribute to its continued success," said Henri Tausch "It's inspiring to see Ketjen's dedi

    6/19/24 7:00:00 AM ET
    $ALB
    Major Chemicals
    Industrials

    International Paper Announces Changes to Its Board of Directors

     Jamie A. Beggs and Scott A. Tozier to Join as Newest Board Members Ilene S. Gordon to Retire from the Board MEMPHIS, Tenn., May 22, 2024 /PRNewswire/ -- International Paper ("IP") (NYSE:IP) announced that Jamie A. Beggs and Scott A. Tozier have been elected to IP's Board of Directors, effective May 21, 2024. The company also announced that Ilene S. Gordon has retired from the Board citing personal and health reasons, effective May 21, 2024. Ms. Beggs, age 47, currently serves as Senior Vice President and Chief Financial Officer of Avient Corporation (NYSE:AVNT), a premier pr

    5/23/24 10:51:00 AM ET
    $ALB
    $AVNT
    $IP
    Major Chemicals
    Industrials
    Paper
    Basic Materials

    Albemarle Reports Net Sales Increase of 60% for Second Quarter 2023

    CHARLOTTE, N.C., Aug. 2, 2023 /PRNewswire/ -- Albemarle Corporation (NYSE:ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced its results for the second quarter ended June 30, 2023. Second-Quarter 2023 and Recent Highlights(Unless otherwise stated, all percentage changes represent year-over-year comparisons) Net sales of $2.4 billion, an increase of 60%Net income of $650.0 million, or $5.52 per diluted share, an increase of 60%Adjusted diluted EPS of $7.33, an increase of 112%Adjusted EBITDA of $1.0 billion, an i

    8/2/23 4:15:00 PM ET
    $ALB
    Major Chemicals
    Industrials

    $ALB
    Financials

    Live finance-specific insights

    View All

    Albemarle Reports Second Quarter 2025 Results

    CHARLOTTE, N.C., July 30, 2025 /PRNewswire/ -- Albemarle Corporation (NYSE:ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced its results for the second quarter ended June 30, 2025. Second-Quarter 2025 and Recent Highlights(Unless otherwise stated, all percentage changes represent year-over-year comparisons) Net sales of $1.3 billion, including volume growth in Energy Storage (+15%) and Specialties (+6%).Net income of $23 million, or ($0.16) per diluted share attributable to common shareholders; adjusted diluted

    7/30/25 4:15:00 PM ET
    $ALB
    Major Chemicals
    Industrials

    Albemarle Announces Quarterly Common Stock Dividend

    CHARLOTTE, N.C., July 22, 2025 /PRNewswire/ -- The Board of Directors of Albemarle Corp. (NYSE:ALB) announced today that it declared a quarterly common stock dividend of $0.405 per share. The dividend, which has an annualized rate of $1.62, is payable October 1, 2025, to shareholders of record at the close of business as of September 12, 2025. About AlbemarleAlbemarle Corp. (NYSE:ALB) leads the world in transforming essential resources into critical ingredients for mobility, energy, connectivity and health. We partner to pioneer new ways to move, power, connect and protect wit

    7/22/25 4:15:00 PM ET
    $ALB
    Major Chemicals
    Industrials

    Albemarle Corporation to Release Second Quarter 2025 Earnings Results on Wednesday, July 30, 2025

    CHARLOTTE, North Carolina, June 18, 2025 /PRNewswire/ -- Albemarle Corporation (NYSE:ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, announced today that it will release its second quarter 2025 earnings after the NYSE closes on Wednesday, July 30, 2025. The company will hold a conference call to discuss its second quarter 2025 results on Thursday, July 31, at 8 a.m. ET. Access to the call is available via webcast or direct dial. A link to the webcast can be found through Albemarle Corporation's website at http://investors.al

    6/18/25 4:15:00 PM ET
    $ALB
    Major Chemicals
    Industrials

    $ALB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Albemarle Corporation

    SC 13G/A - ALBEMARLE CORP (0000915913) (Subject)

    12/5/24 7:27:01 PM ET
    $ALB
    Major Chemicals
    Industrials

    SEC Form SC 13G filed by Albemarle Corporation

    SC 13G - ALBEMARLE CORP (0000915913) (Subject)

    11/13/24 12:52:42 PM ET
    $ALB
    Major Chemicals
    Industrials

    Amendment: SEC Form SC 13G/A filed by Albemarle Corporation

    SC 13G/A - ALBEMARLE CORP (0000915913) (Subject)

    11/13/24 10:27:59 AM ET
    $ALB
    Major Chemicals
    Industrials

    $ALB
    SEC Filings

    View All

    Albemarle Corporation filed SEC Form 8-K: Leadership Update

    8-K - ALBEMARLE CORP (0000915913) (Filer)

    8/12/25 4:32:46 PM ET
    $ALB
    Major Chemicals
    Industrials

    Amendment: SEC Form SCHEDULE 13G/A filed by Albemarle Corporation

    SCHEDULE 13G/A - ALBEMARLE CORP (0000915913) (Subject)

    8/5/25 11:11:06 AM ET
    $ALB
    Major Chemicals
    Industrials

    Albemarle Corporation filed SEC Form 8-K: Leadership Update

    8-K - ALBEMARLE CORP (0000915913) (Filer)

    8/4/25 4:25:49 PM ET
    $ALB
    Major Chemicals
    Industrials